Chimera Investment (NYSE:CIM – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 9th. Analysts expect Chimera Investment to post earnings of $0.10 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
Chimera Investment Price Performance
NYSE CIM opened at $4.28 on Wednesday. The stock has a market capitalization of $1.03 billion, a PE ratio of 18.61 and a beta of 1.68. The stock has a 50-day simple moving average of $4.33 and a 200 day simple moving average of $4.69. The company has a debt-to-equity ratio of 3.00, a quick ratio of 0.12 and a current ratio of 0.12. Chimera Investment has a twelve month low of $3.92 and a twelve month high of $6.49.
Chimera Investment Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 30th. Shareholders of record on Monday, April 8th were given a $0.11 dividend. The ex-dividend date of this dividend was Friday, April 5th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 10.28%. Chimera Investment’s dividend payout ratio is currently 191.30%.
About Chimera Investment
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Recommended Stories
- Five stocks we like better than Chimera Investment
- Why Are Stock Sectors Important to Successful Investing?
- Garmin Navigates to New Highs Driven By Wearables Trend
- How to Capture the Benefits of Dividend Increases
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Options Trading – Understanding Strike Price
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.